2001
DOI: 10.1046/j.1537-2995.2001.41101263.x
|View full text |Cite
|
Sign up to set email alerts
|

K, Fya, and Jka phenotyping of donor RBCs on microplates

Abstract: The PEG-IAT microplate method gave reliable results that were suitable for routine phenotyping, thus making available a stock of phenotyped blood at reasonable cost, ready for delivery when required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 26 publications
0
10
0
Order By: Relevance
“…The Chinese tended to have a lower incidence of Le(a-b-) yet with a similar occurrence of Le(a+b+) at 12% [Table 6]. [4820]…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The Chinese tended to have a lower incidence of Le(a-b-) yet with a similar occurrence of Le(a+b+) at 12% [Table 6]. [4820]…”
Section: Discussionmentioning
confidence: 99%
“…[2] The ABO blood group and D status of blood donors and recipients are always taken into account when RBCs are transfused. [8] Other RBC antigens are usually not considered unless the recipient had previously undergone alloimmunization. This points out to the need to phenotyping RBC units to one or several antigenic systems, since only ABO and Rh (D) are usually typed.…”
Section: Introductionmentioning
confidence: 99%
“…However, the phenotype of clinically significant blood group antigens on the donor red blood cells (RBCs) is required to be known at times when alloimmunization is particularly undesirable, such as in young females, pregnant women, and patients who are expected to require repeated transfusions in life, such as thalassemia or sickle cell disease patients. When selecting blood for transfusion to such patients, it would be useful if we have access to already phenotyped RBCs of donor population so that particular antigen typed blood can be given to such patients to prevent alloimmunization [5]. Furthermore, these are beneficial for already immunized patients if the transfusion is urgent and/or if clinically significant alloantibodies to particular antigen/antigens are present in the patient's serum.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, these are beneficial for already immunized patients if the transfusion is urgent and/or if clinically significant alloantibodies to particular antigen/antigens are present in the patient's serum. In such situations, corresponding antigen negative blood can be given to such recipients without much delay [5]. …”
Section: Introductionmentioning
confidence: 99%
“…14 In the setting of stem cell therapy, delayed red cell engraftment complications due to alloimmunization can be obviated. 57 This prophylactic matching can be accomplished by serologic testing 8,9 or by red cell genotype ‘dry’ matching. 10 …”
Section: Introductionmentioning
confidence: 99%